Natural Alternatives International Inc (NAII) — SEC Filings
Natural Alternatives International Inc (NAII) — 19 SEC filings. Latest: 8-K (Dec 17, 2025). Includes 6 8-K, 6 10-Q, 3 SC 13G/A.
View Natural Alternatives International Inc on SEC EDGAR
Overview
Natural Alternatives International Inc (NAII) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 12, 2025: Natural Alternatives International, Inc. (NAII) filed an 8-K on December 12, 2025, reporting a submission of matters to a vote of security holders on December 5, 2025. The filing does not contain specific details about the matters voted upon or any financial figures.
Sentiment Summary
Across 19 filings, the sentiment breakdown is: 1 bullish, 14 neutral, 4 mixed. The dominant filing sentiment for Natural Alternatives International Inc is neutral.
Filing Type Overview
Natural Alternatives International Inc (NAII) has filed 6 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 3 SC 13G/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (19)
Risk Profile
Risk Assessment: Of NAII's 17 recent filings, 0 were flagged as high-risk, 10 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $37.73M |
| Net Income | -$0.29M |
| EPS | N/A |
| Debt-to-Equity | 1.27 |
| Cash Position | $7.74M |
| Operating Margin | 0.8% |
| Total Assets | $156.95M |
| Total Debt | $97.13M |
Key Executives
- Mark A. LeDoux
- Kenneth E. Wolf
- Alan G. Dunn
- Laura Kay Matherly
- Guru Ramanathan
Industry Context
NAII operates in the nutritional supplement industry, a sector characterized by strong consumer demand for health and wellness products, but also by intense competition and evolving regulatory landscapes. The industry is seeing growth in specialized ingredients and personalized nutrition. Companies like NAII often rely on proprietary formulations and efficient manufacturing to maintain market share.
Top Tags
financials (4) · earnings (4) · 10-Q (3) · amendment (3) · shareholder-vote (2) · corporate-governance (2) · Nutritional Supplements (2) · Beta-Alanine (2) · material-agreement (2) · revenue (2)
Executive Compensation
From the most recent DEF 14A filing (Oct 23, 2025):
- Mark A. LeDoux — Chair of the Board and Chief Executive Officer
- Kenneth E. Wolf — President, Chief Operating Officer, and Secretary
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Sales | $37.73M | Increased from $33.15M in Q1 2024, a 13.8% year-over-year growth. |
| Net Loss | $(0.29)M | Significantly improved from $(1.98)M in Q1 2024. |
| Gross Profit | $4.40M | More than doubled from $2.26M in Q1 2024. |
| Net Cash Used in Operating Activities | $(4.02)M | Increased from $(3.44)M in Q1 2024, indicating higher cash burn. |
| Cash and Cash Equivalents | $7.74M | Decreased from $12.33M at June 30, 2025. |
| Beta-alanine Royalty/Licensing Income | $1.7M | Decreased from $2.5M in Q1 2024. |
| Accounts Receivable | $18.91M | Increased from $14.64M at June 30, 2025, suggesting potential for future cash inflow but also collection risk. |
| Inventories, net | $30.65M | Increased from $24.87M at June 30, 2025, indicating higher stock levels. |
| Accounts Payable | $20.10M | Increased from $15.35M at June 30, 2025. |
| Common Shares Outstanding | 6,176,778 | As of November 12, 2025. |
| Annual Meeting Date | December 5, 2025 | Date of the virtual Annual Meeting of Stockholders |
| Annual Meeting Time | 11:00 AM Pacific Time | Scheduled start time for the virtual Annual Meeting |
| Additional Shares | 550,000 | Number of common shares proposed to be added to the 2020 Equity Incentive Plan |
| Record Date | October 13, 2025 | Date for determining stockholders entitled to vote at the Annual Meeting |
| Outstanding Shares | 6,176,778 | Total shares of common stock issued and outstanding as of the record date |
Forward-Looking Statements
- {"claim":"Natural Alternatives International Inc. will likely face continued pressure on its net sales in the next quarter.","entity":"Natural Alternatives International Inc.","targetDate":"2024-03-31","confidence":"medium"}
- {"claim":"The company's profitability will remain challenged in the near term due to declining sales.","entity":"Natural Alternatives International Inc.","targetDate":"2024-06-30","confidence":"medium"}
- {"claim":"Renaissance Technologies LLC will maintain a significant stake in Natural Alternatives International, Inc. for the foreseeable future.","entity":"Renaissance Technologies LLC","targetDate":"December 29, 2024","confidence":"medium"}
- {"claim":"Dimensional Fund Advisors LP will maintain a significant stake in Natural Alternatives International Inc. for the foreseeable future.","entity":"Dimensional Fund Advisors LP","targetDate":"December 29, 2024","confidence":"medium"}
Frequently Asked Questions
What are the latest SEC filings for Natural Alternatives International Inc (NAII)?
Natural Alternatives International Inc has 19 recent SEC filings from Feb 2024 to Dec 2025, including 6 8-K, 6 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of NAII filings?
Across 19 filings, the sentiment breakdown is: 1 bullish, 14 neutral, 4 mixed. The dominant sentiment is neutral.
Where can I find Natural Alternatives International Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Natural Alternatives International Inc (NAII) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Natural Alternatives International Inc?
Key financial highlights from Natural Alternatives International Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for NAII?
The investment thesis for NAII includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Natural Alternatives International Inc?
Key executives identified across Natural Alternatives International Inc's filings include Mark A. LeDoux, Kenneth E. Wolf, Alan G. Dunn, Laura Kay Matherly, Guru Ramanathan.
What are the main risk factors for Natural Alternatives International Inc stock?
Of NAII's 17 assessed filings, 0 were flagged high-risk, 10 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Natural Alternatives International Inc?
Recent forward-looking statements from Natural Alternatives International Inc include guidance on {"claim":"Natural Alternatives International Inc. will likely face continued pressure on its net sales in the next quart and 3 other predictions.